Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles

American Journal of Transplantation

Volumn 2, Issue 6, 2002, Pages 526-534

  Dujovny, Nadav ^a   Varghese, Anncy ^a   Shen, Jikun ^a   Yin, Dengping ^a   Ji, Shaoquan ^c   Ma, LianLi ^b   Finnegan, Alison ^a   Chong, Anita S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Linco Research Inc   (United States)

^c NONE

Author keywords

Allografts; Cytokines; IgG isotypes; IgM; Interferon gamma; Interleukin 4; Transplantation; Xenograft

Indexed keywords

ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT REJECTION; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; MOUSE STRAIN; NONHUMAN; TH1 CELL; TH2 CELL; XENOGRAFT;

ANIMALS; ANTIBODIES; CYTOKINES; GRAFT REJECTION; HEART TRANSPLANTATION; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036664313     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20606.x     Document Type: Article

References (26)

1. Wang H, DeVries ME, Deng S et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med 2000; 6: 549-555.
2. Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 1991; 21: 152-158.
3. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
4. Mosmann T, Coffman R. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
5. Del Prete G, Romagnani S. The role of TH1 and TH2 subsets in human infectious diseases. Trends Microbiol 1994; 2: 4-6.
6. London C, Abbas A, Kelso A. Helper T cell subsets: heterogeneity, functions and development. Vet Immunol Immunopathol 1998; 63: 37-44.
7. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275-283.
8. Finkelman F, Holmes J, Katona I et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303.
9. Seder R, Paul W. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12: 635-673.
10. Abbas A, Murphy K, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793.
11. Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59 (8): 1155-1161.
12. Thai N, Fu F, Qian S et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 1995; 59: 274-281.
13. Strom TB, Roy-Chaudhury P, Manfro R et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8 (5): 688-693.
14. Mueller R, Davies JD, Krahl T, Sarvetnick N. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. J Immunol 1997; 159 (4): 1599-1603.
15. Kupiec-Weglinski J, Wasowska B, Papp I et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053-5061.
16. Simeonovic C, Townsend M, Karupiah G et al. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response. Cell Transplant 1999; 8: 365-373.
17. Simeonovic C, Townsend M, Morris C et al. Immune mechanisms associated with the rejection of fetal murine proislet allografts and pig proislet xenografts: comparison of intragraft cytokine mRNA profiles. Transplantation 1999; 67: 963-971.
18. Wren SM, Wang SC, Thai NL et al. Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation 1993; 56 (4): 905-911.
19. Kishimoto K, Furukawa K, Ashizuka S, Sawada T, Ayabe H. Profile of cytokine production during the inhibition of acute xenograft rejection. Surg Today 2000; 30 (2): 159-162.
20. Finkelman FD, Morris SC. Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol 1999; 11 (11): 1811-1818.
21. Chong A, Blinder L, Ma L et al. Anti-galactose-alpha (1,3) galactose antibody production in alpha 1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol 2000; 8 (2): 129-137.
22. Chong AS, Ma L, Yin D et al. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha 1.3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation 2000; 7 (4): 275-283.
23. Matesic D, Lehmann P, Heeger P. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65: 906-914.
24. Larsson LC, Czech KA, Widner H, Korsgren O. Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. Transplantation 1999; 68 (8): 1153-1160.
25. Yin D, Ma L, Shen J, Byrne G, Logan JS, Chong AS. CTLA-4Ig in combination with anti-CD40L prolongs xenograft survival and inhibits anti-Gal Ab production in GT-Ko mice. Am J Transplant 2002; 2: 41-47.
26. Faquim-Mauro EL, Coffman RL, Abrahamsohn IA, Macedo MS. Cutting edge mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J Immunol 1999; 163 (7): 3572-3576.